These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 215555)

  • 21. [Azidocillin: activity in vitro, pharmacokinetics and therapeutic results in whooping cough].
    Simon C; Junk W; Malerczyk V
    Arzneimittelforschung; 1976; 26(3):424-6. PubMed ID: 183785
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Direct Detection of Erythromycin-Resistant Bordetella pertussis in Clinical Specimens by PCR.
    Wang Z; Han R; Liu Y; Du Q; Liu J; Ma C; Li H; He Q; Yan Y
    J Clin Microbiol; 2015 Nov; 53(11):3418-22. PubMed ID: 26224847
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High prevalence of erythromycin-resistant Bordetella pertussis in Xi'an, China.
    Wang Z; Cui Z; Li Y; Hou T; Liu X; Xi Y; Liu Y; Li H; He Q
    Clin Microbiol Infect; 2014 Nov; 20(11):O825-30. PubMed ID: 24816168
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Erythromycin-resistant Bordetella pertussis--Yuma County, Arizona, May-October 1994.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1994 Nov; 43(44):807-10. PubMed ID: 7968996
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The carrier state: Bordetella pertussis.
    Lambert HP
    J Antimicrob Chemother; 1986 Jul; 18 Suppl A():13-6. PubMed ID: 2875052
    [No Abstract]   [Full Text] [Related]  

  • 26. Whooping cough--aspects of pathogenesis and treatment.
    Trollfors B
    Acta Otolaryngol Suppl; 1984; 407():33-9. PubMed ID: 6093425
    [No Abstract]   [Full Text] [Related]  

  • 27. Limitations of erythromycin in whooping cough.
    Henry R; Dorman D; Skinner J; Mellis C
    Med J Aust; 1981 Jul; 2(2):108-9. PubMed ID: 6272070
    [No Abstract]   [Full Text] [Related]  

  • 28. Antimicrobial susceptibility testing of Bordetella pertussis in Taiwan prompted by a case of pertussis in a paediatric patient.
    Yao SM; Liaw GJ; Chen YY; Yen MH; Chen YH; Mu JJ; Chiang CS
    J Med Microbiol; 2008 Dec; 57(Pt 12):1577-1580. PubMed ID: 19018032
    [TBL] [Abstract][Full Text] [Related]  

  • 29. From the Centers for Disease Control and Prevention. Erythromycin-resistant Bordetella pertussis--Yuma County, Arizona, May-October 1994.
    JAMA; 1995 Jan; 273(1):13-4. PubMed ID: 7996637
    [No Abstract]   [Full Text] [Related]  

  • 30. Antimicrobial drugs in the treatment and prevention of pertussis.
    Lambert H
    J Antimicrob Chemother; 1979 Jul; 5(4):329-31. PubMed ID: 226510
    [No Abstract]   [Full Text] [Related]  

  • 31. Trends in the Minimum Inhibitory Concentrations of Erythromycin, Clarithromycin, Azithromycin, Ciprofloxacin, and Trimethoprim/Sulfamethoxazole for Strains of Bordetella pertussis isolated in the Czech Republic in 1967-2015.
    Jakubů V; Zavadilová J; Fabiánová K; Urbášková P
    Cent Eur J Public Health; 2017 Dec; 25(4):282-286. PubMed ID: 29346850
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of erythromycin to prevent pertussis in newborns of mothers with pertussis.
    Granström G; Sterner G; Nord CE; Granström M
    J Infect Dis; 1987 Jun; 155(6):1210-4. PubMed ID: 2883239
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of antibiotic sensitivity and resistance genes of Bordetella pertussis in Chinese children.
    Lin X; Zou J; Yao K; Li L; Zhong L
    Medicine (Baltimore); 2021 Jan; 100(2):e24090. PubMed ID: 33466172
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of antibiotics, immunizations, and adenoviruses in pertussis.
    Baraff LJ; Wilkins J; Wehrle PF
    Pediatrics; 1978 Feb; 61(2):224-30. PubMed ID: 204899
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of erythromycin treatment on antibody responses in pertussis.
    Granström G; Granström M
    Scand J Infect Dis; 1994; 26(4):453-7. PubMed ID: 7984978
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Simplified treatment of acute lower respiratory tract infection with azithromycin: a comparison with erythromycin and amoxycillin. European Azithromycin Study Group.
    Daniel R
    J Int Med Res; 1991; 19(5):373-83. PubMed ID: 1660824
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibiotic treatment of Haemophilus influenzae and Haemophilus parainfluenzae infections in patients with cystic fibrosis.
    Pressler T; Szaff M; Høiby N
    Acta Paediatr Scand; 1984 Jul; 73(4):541-7. PubMed ID: 6331710
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modifying antibiotic treatment strategies in the face of pertussis surge associated to erythromycin resistance in China.
    Shi W; Meng Q; Hu Y; Yao K
    J Infect; 2024 Jun; 88(6):106174. PubMed ID: 38719109
    [No Abstract]   [Full Text] [Related]  

  • 39. Seven days of erythromycin estolate is as effective as fourteen days for the treatment of Bordetella pertussis infections.
    Halperin SA; Bortolussi R; Langley JM; Miller B; Eastwood BJ
    Pediatrics; 1997 Jul; 100(1):65-71. PubMed ID: 9200361
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Where macrolide resistance is prevalent.
    Li Y; Liu X; Zhang B; He Q; Wang Z
    APMIS; 2015 Apr; 123(4):361-3. PubMed ID: 25703275
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.